Patent ID: 11935637
Assignee: INSULET CORPORATION
Field: Medical technology (Instruments)
Classification: CPC G  A | IPC A  G

Claim 8:
9. The non-transitory computer readable medium of claim 1, further embodied with programming code as part of the artificial pancreas application executable by the processor, and the processor when executing the programming code to determine whether the portion of the insulin delivery history meets sufficiency requirements, is operable to:
determine that the portion of the insulin delivery history fails to meet the sufficiency requirements;
in response to a determination that the insulin delivery history fails to meet the sufficiency requirements, select a lower safety boundary for an amount of insulin to be delivered for a period of time, wherein the selected lower safety boundary is lower than the selected upper safety boundary and greater than a minimum amount of insulin to be delivered by the drug delivery device; and
limits the amount of insulin delivered by the wearable drug delivery device to at or below the selected lower safety boundary.